摘要
[目的]观察中西医结合治疗肺源性心脏病的临床疗效。[方法]116例肺心病患者随机分为三组:A组(西医组)38例采用西医常规治疗,B组(中医组)36例以补肺脾肾、益肺温阳、祛痰化瘀中药治疗,C组(中西医结合组)42例在抗感染、吸氧、纠正水/电解质平衡基础上加用参麦与灯盏花素注射液静滴;比较各组临床疗效和血液流变学指标改善情况。[结果]C组总有效率95.24%,与A组(68.42%)和B组(75.0%)比较,差异有显著性(P<0.05)。且在临床症状和体征改善方面也明显优于其它两组。[结论]中西医结合治疗肺心脏病有利于改善血气分析指标,疗效确切。
[Objective] To observe the traditional Chinese and western medicine treatment of pulmonary heart disease in clinical efficacy. [Methods] 116 cases of pulmonary heart disease were randomly divided into three groups; A group (TCM group) 38 cases of the use of conventional Western medicine treatment, B group (TCM group) to 36 cases of spleen and kidney Bufei, Yifei Onyang, expectorant blood Chinese medicine treatment, C group (traditional Chinese and western medicine group) in 42 cases of anti-infection, oxygen, correct water / electrolyte balance plus intravenous injection Shenmai and Breviscapine; compare the clinical efficacy and hemorrheology indicators to improve the situation. [Results]C group, the total efficiency of 95. 24% , with the A group (68.42% ) and B group (75. 0% ) , the difference was significant ( P < 0. 05 ) . And in the improvement of clinical symptoms and signs are also much better than the other two groups. [ Conclusion] The traditional Chinese and western medicine treatment of pulmonary heart disease, blood gas analysis will help to improve the indicators and effective.
出处
《实用中医内科杂志》
2009年第9期64-65,共2页
Journal of Practical Traditional Chinese Internal Medicine
关键词
慢性肺心病
临床观察
血气分析
中西医结合疗法
chronic pulmonary heart disease
clinical observation
blood gas analysis
traditional chi-nese and western medicine
